CONNIE LIN: Open Payments
NPI 1265100317 · GARDEN GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 36 payments from 14 companies in 2025. Trend: 2023 $2,014 · 2024 $2,591 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $268 |
| Madrigal Pharmaceuticals | 3 | $109 |
| Ardelyx, Inc. | 3 | $88 |
| QOL Medical, LLC | 2 | $65 |
| PFIZER INC. | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $28 |
| Sandoz Inc. | 1 | $26 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $24 |
Products named: RINVOQ, REZDIFFRA, SKYRIZI, IBSRELA, Sucraid, DUPIXENT, LINZESS, OMVOH.
Industry payments across CA — which companies pay providers there.
